Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.34 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17349637 | 0.93 | MEN1 (0.43) | L3MBTL1KDM4EATMRXRAKMT2A | |
| SCHEMBL18958652 | 0.93 | MEN1 (0.43) | L3MBTL1KDM4EATMRXRAKMT2A | |
| SCHEMBL17339038 | 0.91 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMKMT2AHDAC4 | |
| SCHEMBL30665725 | 0.91 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMKMT2AHDAC4 | |
| SCHEMBL17339033 | 0.90 | KDM4E (0.37) | L3MBTL1KDM4EATMKMT2AABCG2 | |
| SCHEMBL17339009 | 0.90 | L3MBTL1 (0.37) | L3MBTL1ABCG2 | |
| SCHEMBL17349636 | 0.85 | ADORA3 (0.37) | L3MBTL1KDM4EATMKMT2AHDAC4 | |
| SCHEMBL17349641 | 0.85 | ADORA3 (0.37) | L3MBTL1KDM4EATMKMT2AHDAC4 | |
| SCHEMBL29533970 | 0.85 | KDM4E (0.55) | L3MBTL1KDM4EATMKMT2A | |
| SCHEMBL15590611 | 0.85 | KDM4E (0.55) | L3MBTL1KDM4EATMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170170407-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD (KR) | 2017-06-15 | — | — | US | disclosed |
| US-20170170407-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD (KR) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170170407-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | OR10J3, OR51E2, ETV6 | L3MBTL1 1793/4885KDM4E 148/4885ATM 3430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.